Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer:a phase II study-Reference-Cited by-同舟云学术

Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer:a phase II study

Published:2002-08 Issue:8 Volume:13 Page:1197-1204
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hegewisch-Becker S.,Gruber Y.,Corovic A.,Pichlmeier U.,Atanackovic D.,Nierhaus A.,Hossfeld D.K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/8/1197/334202/mdf216.pdf

Reference46 articles.

1. Irinotecan in the treatment of colorectal cancer: clinical overview;Vanhoefer;J Clin Oncol,2001

2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

3. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer;de Gramont;Eur J Cancer,1997

4. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6);Maindrault-Goebel;Eur J Cancer,1999

5. Weekly high-dose (HD) 5‐fluorouracil (5-FU) and folinic acid (FA) with addition of oxaliplatin (LOHP) after documented progression under high-dose infusional 5-FU/FA in patients (pts) with advanced colorectal cancer (CRC);Buechele;Ann Hematol,1998

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem;Theranostics;2023

2. Systematic review about complementary medical hyperthermia in oncology;Clinical and Experimental Medicine;2022-06-29

3. Studie zur ambulanten moderaten Ganzkörperhyperthermie bei Fibromyalgiesyndrom;Erfahrungsheilkunde;2022-06

4. Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas;Cancers;2022-01-29

5. Zentrale Empfehlungen und Statements der S3-Leitlinie zur komplementären Medizin für Patient*innen mit onkologischen Erkrankungen – Teil 2;Der Onkologe;2021-07-07